Diagnosis and treatment of type 2 diabetes mellitus in patients with chronic kidney disease and eGFR < 60 mL/min - a position statement of the Polish Society of Nephrology Working Group on Metabolic and Endocrine Disorders in Kidney Diseases.

Author: AdamczakMarcin, Masajtis-ZagajewskaAnna, MazanowskaOktawia, MaziarskaKatarzyna, StompórTomasz, WitkowskaAgnieszka, WięcekAndrzej

Paper Details 
Original Abstract of the Article :
Diabetes mellitus is one the most frequent co-morbid conditions in patients with chronic kidney disease (CKD), frequently leading to chronic kidney failure. Progression of CKD accelerates several metabolic disorders, predominantly those related to abnormalities of carbohydrate metabolism. Patients w...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.5603/EP.a2019.0064

データ提供:米国国立医学図書館(NLM)

Navigating Diabetes in the Desert of Kidney Disease: A Guide for Nephrologists

The presence of both diabetes and chronic kidney disease (CKD) is like a double whammy for a camel, each ailment adding its own unique set of challenges to an already harsh environment. This position statement, a beacon of guidance for nephrologists, delves into the complex interplay between diabetes and CKD, providing practical recommendations for diagnosis and treatment. The authors highlight the prevalence of diabetes in CKD patients, often accelerating the progression of kidney disease. The statement emphasizes the importance of carefully managing anti-diabetic medications in CKD patients, as reduced kidney function necessitates adjustments in dosage. The authors also address the increased risk of hypoglycemia and other adverse drug reactions in CKD patients, a crucial consideration when selecting treatment options.

A Well-Marked Path: Practical Recommendations for Nephrologists

This position statement offers a roadmap for nephrologists, providing clear guidance on managing diabetes in CKD patients. The authors' emphasis on individualized treatment plans, dosage adjustments, and risk management strategies underscores the importance of careful monitoring and expert intervention in these complex cases.

Health Benefits and Daily Application

If you're living with diabetes and CKD, it's essential to work closely with your healthcare team to create a personalized treatment plan. Regular monitoring, adherence to medication regimens, and a healthy lifestyle are crucial for managing both conditions and improving your overall well-being.

Dr. Camel's Conclusion

This position statement provides valuable insights into the challenges of managing diabetes in CKD patients. It's a reminder that just as a camel must adapt to the desert's harsh conditions, individuals with diabetes and CKD require careful attention and tailored treatment plans to thrive in this complex environment. By combining knowledge, experience, and a commitment to personalized care, nephrologists can navigate this difficult terrain and help their patients achieve optimal health outcomes.

Date :
  1. Date Completed 2020-12-17
  2. Date Revised 2020-12-17
Further Info :

Pubmed ID

32129464

DOI: Digital Object Identifier

10.5603/EP.a2019.0064

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.